Description:GW2580 is a small molecule inhibitor primarily known for its role as a selective antagonist of the colony-stimulating factor 1 receptor (CSF1R). This compound has garnered attention in the field of cancer research and immunology due to its potential to modulate the tumor microenvironment by inhibiting macrophage recruitment and activation. GW2580 is characterized by its ability to interfere with CSF1 signaling pathways, which are crucial for the survival and proliferation of macrophages. The compound is typically studied in preclinical models to evaluate its efficacy in various cancer types and inflammatory diseases. In terms of its chemical properties, GW2580 is a synthetic compound with a specific molecular structure that allows it to bind selectively to CSF1R, thereby blocking its activity. Its pharmacokinetics, including absorption, distribution, metabolism, and excretion (ADME) profiles, are also important considerations in its development as a therapeutic agent. Overall, GW2580 represents a promising avenue for targeted therapies aimed at modulating immune responses in disease contexts.
Please enquire for more information about 5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine including the price, delivery time and more detailed …
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine](https://static.cymitquimica.com/products/3D/thumb/FM31223.jpg)
